Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2008
12/04/2008US20080299176 Drug delivery device comprising crosslinked polyurethane-siloxane-containing copolymers
12/04/2008US20080299170 Medical Devices and Coatings Therefor
12/04/2008US20080299168 Stabilized Polymeric Delivery System
12/04/2008US20080299166 Novel biomaterials, their preparation and use
12/04/2008US20080299165 Compositions for Treatment of Diseases of the Nail Unit
12/04/2008US20080299164 Substituted polycaprolactone for coating
12/04/2008US20080299153 B. anthracis prevention and treatment: mutant b. anthracis lacking luxs activity and furanone inhibition of growth, ai-2 quorum sensing, and toxin production
12/04/2008US20080299151 Influenza vaccines
12/04/2008US20080299147 Microalgae-Derived Compositions For Improving The Health And Appearance Of Skin
12/04/2008US20080299142 Compounds and methods for treatment and diagnosis of chlamydial infection
12/04/2008US20080299138 Toll-Like Receptor 3 Modulators and Uses Thereof
12/04/2008US20080299137 Fusion Proteins That Bind Effector Lymphocytes And Target Cells
12/04/2008US20080299135 Methods and compositions for nerve regeneration
12/04/2008US20080299130 Methods And Compositions For The Treatment Of Ocular Neovascularization
12/04/2008US20080299125 Genetic basis of treatment response in depression patients
12/04/2008US20080299123 Treatment of chemotherapy- or radiotherapy-resistant tumors
12/04/2008US20080299118 FXR Agonists for the Treatment of Malignancies
12/04/2008US20080299113 Combined treatment with and composition of 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitor and anti-cancer agents
12/04/2008US20080299111 Prevention, treatment and diagnosis of diseases associated with beta-amyloid formation and/or aggregation
12/04/2008US20080299104 Methods for detecting agents involved in neuronal apoptosis and compositions thereof
12/04/2008US20080299101 Cancer Treatment Resistance and Agents Modulating Such Resistance
12/04/2008US20080299100 Topical Co-Enzyme Q10 Formulations and Methods of Use
12/04/2008US20080299095 Nup98-Hox Fusions for Expansion of Hemopoietic Stem Cells
12/04/2008US20080299089 Endogeneous repair factor production promoters
12/04/2008US20080299084 Bacterially derived intact minicells that encompass plasma free functional nucleic acid for in vivo delivery to mammalian cells
12/04/2008US20080299083 Adenoviral vectors having a protein IX deletion
12/04/2008US20080299081 Polynucleotides and Polypeptides of the IFNalpha-21 Gene
12/04/2008US20080299080 Thiophene analogues for the treatment or prevention of flavivirus infections
12/04/2008US20080299079 Absorption Enhancers for Drug Administration
12/04/2008US20080299076 Compunds and compositions that cause non-apoptotic cell death and uses thereof
12/04/2008US20080299075 a mixture of viricides such as dimethyl(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl((1S)-2-methyl-1,1-propanediyl)imino((2S)-1-oxo-1,2-propanediyl)))biscarbamate, carriers and one or two additional antiviral drugs, used for the treatment of viral infections
12/04/2008US20080299070 Antiviral Compounds
12/04/2008US20080299068 Skin Preparation For External Use
12/04/2008US20080299067 Functionalised Siloxanes for Scar Tissue Treatment
12/04/2008US20080299060 Pharmaceutical Composition for the Treatment of Nail Diseases
12/04/2008US20080299058 Multi-formulation cosmetic compositions
12/04/2008US20080299054 Personal care compositions with enhanced fragrance delivery
12/04/2008US20080299053 Enhanced delivery of certain fragrance components from personal care compositions
12/04/2008US20080299050 Topical therapies for oral mucositis and other conditions
12/04/2008US20080299005 film made of water soluble polymer such as hydroxypropyl cellulose, hydroxymethyl propyl cellulose, a reagent such as protein, hormone, antibody and an enzyme; film disintegrates upon contact with an aqueous fluid to release the reagent which reacts human chorionic gonadotrophin in saliva, urine, blood
12/04/2008DE102007025908A1 Formulierungen enthaltend Triazinone und Eisen Formulations containing triazinones and iron
12/04/2008DE102007025898A1 Behandlung von Surfactanten Treatment of surfactants
12/04/2008DE102007025718A1 Pyridazinonderivate Pyridazinone derivatives
12/04/2008DE102007025423A1 Triphenylphosphonium-Derivate zum gezielten Transport und Freisetzen von Substanzen in Mitochondrien sowie Verfahren zu deren Verwendung Triphenylphosphonium derivatives for targeted delivery and release of substances in mitochondria and methods for their use
12/04/2008CA2689664A1 Cancer treatment combination therapy comprising vinflunine and trastuzumab
12/04/2008CA2689090A1 Kinase inhibitor
12/04/2008CA2688613A1 Formulations containing triazinones and iron
12/04/2008CA2688599A1 Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
12/04/2008CA2688570A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
12/04/2008CA2688518A1 Pyridazinone derivatives for use in the treatment of a disease which is influenced by inhibiton of met kinase
12/04/2008CA2688517A1 Aryl ether pyridazinone derivatives for use in the treatment of tumours
12/04/2008CA2688495A1 Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
12/04/2008CA2688486A1 Sesquiterpene formulations, kits and methods of use thereof
12/04/2008CA2688394A1 Novel compounds and pharmaceutical preparations
12/04/2008CA2688381A1 Once daily oral dosage form comprising tacrolimus
12/04/2008CA2688375A1 Spirocyclopropyl piperidine derivatives
12/04/2008CA2688344A1 Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
12/04/2008CA2688327A1 Methods and compositions for stimulating cells
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2688293A1 Dietary formulations and methods for treatment of inflammation and other disorders
12/04/2008CA2688194A1 Antiviral drugs for treatment or prevention of dengue infection
12/04/2008CA2688111A1 Cholesterol-interacting layered phyllosilicates and methods of reducing hypercholesteremia in a mammal
12/04/2008CA2688110A1 Azacyclylbenzamide derivatives as histamine-3 antagonists
12/04/2008CA2688074A1 Pharmaceutical formulation comprising pramipexole
12/04/2008CA2688036A1 Formulations for the oral administration of therapeutic agents and related methods
12/04/2008CA2688004A1 Modulators of cystic fibrosis transmembrane conductance regulator
12/04/2008CA2687983A1 Coated hyaluronic acid particles
12/04/2008CA2687976A1 Therapeutic ((phenyl)imidazolyl)methylquinolinyl compounds
12/04/2008CA2687973A1 ((bicylicheteroaryl) imidazolyl)methylheteroaryl compounds as adrenergic receptor agonists
12/04/2008CA2687966A1 Thiazoles and pyrazoles useful as kinase inhibitors
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/04/2008CA2687942A1 Therapeutic agent for cerebral infarction
12/04/2008CA2687941A1 Tetracyclic inhibitors of fatty acid amide hydrolase
12/04/2008CA2687931A1 Ccr2 receptor antagonists and uses thereof
12/04/2008CA2687821A1 Benzimidazolone chymase inhibitors
12/04/2008CA2687817A1 Heteroaryl substituted thiazoles
12/04/2008CA2687790A1 Antifungal agents
12/04/2008CA2687786A1 Combination of chk and parp inhibitors for the treatment of cancers
12/04/2008CA2687766A1 Azaindazole compounds and methods of use
12/04/2008CA2687765A1 Pyrazolopyrrolidines as inhibitors of gamma secretase
12/04/2008CA2687764A1 Ion channel modulators and methods of use
12/04/2008CA2687747A1 Non-nucleoside reverse transcriptase inhibitors
12/04/2008CA2687608A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
12/04/2008CA2687574A1 Compositions useful for reducing nephrotoxicity and methods of use thereof
12/04/2008CA2687381A1 Method of treating diabetes
12/04/2008CA2687365A1 4,4-disubstituted piperidine derivatives
12/04/2008CA2687321A1 Pyridyl piperidine orexin receptor antagonists
12/04/2008CA2687310A1 Rapidly dispersible vaginal tablet that provides a bioadhesive gel
12/04/2008CA2686787A1 Raf inhibitors for the treatment of thyroid cancer
12/04/2008CA2686635A1 Pharmaceutical compositions for the treatment of pain
12/04/2008CA2686560A1 Prophylactic or therapeutic agent for age-related macular degeneration
12/04/2008CA2684902A1 Edible composition comprising a slowly digestible or digestion resistant oligosaccharide composition
12/04/2008CA2684174A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of motor disorders related to parkinson's disease
12/04/2008CA2684172A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of spinal cord traumas
12/04/2008CA2684171A1 Use of 4-cyclopropylmethoxy-n-(3,5-dichloro-1-oxidopyridin-4-yl)-5-(methoxy)pyridine-2-carboxamide for the treatment of cranial traumas
12/04/2008CA2683936A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008CA2683933A1 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008CA2683929A1 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof
12/04/2008CA2677892A1 Neurogenic compounds
12/04/2008CA2674967A1 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses